Literature DB >> 11306695

High-intensity p38 kinase activity is critical for p21(cip1) induction and the antiproliferative function of G(i) protein-coupled receptors.

F Alderton1, P P Humphrey, L A Sellers.   

Abstract

G protein-coupled receptors can stimulate the p38 kinase cascade, but the effect this has on cell growth remains poorly characterized. Here we show human somatostatin sst(2) and sst(4) receptors inhibit basic fibroblast growth factor (bFGF)-induced proliferation, via a mechanism that was blocked by the p38 inhibitor PD 169316. The sst(4) receptor could also induce a proliferative activity in the absence of bFGF, which was unaffected by PD 169316. In contrast, the sst(3) receptor had no effect on basal cell growth or on the proliferation evoked by bFGF. The extracellular signal-regulated kinase activity stimulated by the sst(3) receptor was transient in duration compared with a sustained activity induced by the sst(2) and sst(4) receptors and which was critical for the proliferative response of the latter receptor. In addition, activated sst(2) and sst(4) but not sst(3) receptors evoked a prolonged phosphorylation of p38 that was amplified by bFGF. The accumulation of the cell cycle inhibitor p21(cip1) was only apparent after sst(2) and sst(4) receptor activation in the presence of bFGF, which was sensitive to PD 169316 or pertussis toxin. Thus, the contrasting antiproliferative effects evoked by the human sst(2), sst(3), and sst(4) receptors can be accounted for by their differential abilities to activate p38. This activity is critical for p21(cip1) induction, blockade of entry into S phase, as indicated by the lack of retinoblastoma protein phosphorylation, and the associated antiproliferative activity of somatostatin. Furthermore, by changing the intracellular signaling threshold of p38 through cooperative effects of somatostatin and bFGF, the sst(4) receptor can mediate opposing effects on cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306695     DOI: 10.1124/mol.59.5.1119

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  18 in total

1.  Growth inhibition by the muscarinic M(3) acetylcholine receptor: evidence for p21(Cip1/Waf1) involvement in G(1) arrest.

Authors:  Drew Burdon; Rajnikant Patel; R A John Challiss; Jonathan L Blank
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

2.  An enteroendocrine cell-based model for a quiescent intestinal stem cell niche.

Authors:  I R Radford; P N Lobachevsky
Journal:  Cell Prolif       Date:  2006-10       Impact factor: 6.831

3.  p21 shapes cancer evolution.

Authors:  Vasily S Romanov; K Lenhard Rudolph
Journal:  Nat Cell Biol       Date:  2016-06-28       Impact factor: 28.824

4.  p38 mitogen-activated protein kinase inhibits USP22 transcription in HeLa cells.

Authors:  Jianjun Xiong; Zhen Gong; Xiaou Zhou; Jianyun Liu; H E Jiang; Ping Wu; Weidong Li
Journal:  Biomed Rep       Date:  2015-04-16

Review 5.  International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.

Authors:  Thomas Günther; Giovanni Tulipano; Pascal Dournaud; Corinne Bousquet; Zsolt Csaba; Hans-Jürgen Kreienkamp; Amelie Lupp; Márta Korbonits; Justo P Castaño; Hans-Jürgen Wester; Michael Culler; Shlomo Melmed; Stefan Schulz
Journal:  Pharmacol Rev       Date:  2018-10       Impact factor: 25.468

6.  Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors.

Authors:  Jonathan Strosberg; Larry Kvols
Journal:  World J Gastroenterol       Date:  2010-06-28       Impact factor: 5.742

7.  Hypoxia effects on proangiogenic factors in human umbilical vein endothelial cells: functional role of the peptide somatostatin.

Authors:  Massimo Dal Monte; Davide Martini; Chiara Ristori; Danilo Azara; Chiara Armani; Alberto Balbarini; Paola Bagnoli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-04-28       Impact factor: 3.000

8.  Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity.

Authors:  Sara Arena; Federica Barbieri; Stefano Thellung; Paolo Pirani; Alessandro Corsaro; Valentina Villa; Patrizia Dadati; Alessandra Dorcaratto; Gabriella Lapertosa; Jean-Louis Ravetti; Renato Spaziante; Gennaro Schettini; Tullio Florio
Journal:  J Neurooncol       Date:  2004-01       Impact factor: 4.130

9.  p38 differentially regulates ERK, p21, and mitogenic signalling in two pancreatic carcinoma cell lines.

Authors:  Monica Aasrum; G Hege Thoresen; Thoralf Christoffersen; Ingvild J Brusevold
Journal:  J Cell Commun Signal       Date:  2018-01-29       Impact factor: 5.782

10.  Somatostatin stimulates menin gene expression by inhibiting protein kinase A.

Authors:  Edith Mensah-Osman; Yana Zavros; Juanita L Merchant
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-08-28       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.